Insider Trading activities at Niagen Bioscience, Inc. (NAGE)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Niagen Bioscience, Inc. (NAGE) since 2016 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Niagen Bioscience, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1386570.

Total stock buying since 2016: $26,547,845.
Total stock sales since 2016: $1,887,752.
Total stock option exercises since 2016: $1,316,310.


18 insiders reported insider trading activities at Niagen Bioscience, Inc. (NAGE):
Insider trading activities of Allen Stephen R.
Insider trading activities of Chau Hoi Shuen Solina Holly
Insider trading activities of Lopez Carlos Luis
Insider trading activities of Farr Kevin M
Insider trading activities of Jaksch Frank L Jr
Insider trading activities of Radiant Treasure Ltd
Insider trading activities of Dvorak International Ltd
Insider trading activities of Mayspin Management Ltd
Insider trading activities of Pamir Ozan
Insider trading activities of Gerber Brianna
Insider trading activities of Li Ka Shing
Insider trading activities of Friedman Mark J
Insider trading activities of Fried Robert N
Insider trading activities of Shing Li Ka
Insider trading activities of Block Stephen A
Insider trading activities of Rhonemus Troy Allen
Insider trading activities of Patrick Kristin
Insider trading activities of Rubin Steven D

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Niagen Bioscience, Inc. (NAGE).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 6,958 $47,803 0 $0 66,667 $220,001
2024 11,411,622 $21,395 11,468,876 $312,062 73,001 $221,068
2023 3,493,778 $39,040 0 $0 22,436 $0
2022 1,125,037 $1,453,901 0 $0 0 $0
2021 10,000 $66,500 52,500 $625,775 52,500 $114,500
2020 6,000 $26,840 37,829 $196,332 41,667 $192,501
2019 46,378 $169,671 24,390 $85,565 43,334 $65,001
2018 22,800 $82,613 53,431 $300,143 53,431 $240,439
2017 9,017,938 $24,553,337 58,400 $361,496 58,400 $262,800
2016 26,300 $86,745 5,063 $6,379 0 $0

Table 2. Monthly summary of insider trading at Niagen Bioscience, Inc. (NAGE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-11 6,685 $45,658 0 $0 0 $0
2025-04 0 $0 0 $0 66,667 $220,001
2025-03 273 $2,145 0 $0 0 $0
2024-12 0 $0 37,161 $229,952 50,001 $183,003
2024-11 2,907 $21,395 0 $0 0 $0
2024-08 11,408,715 $0 11,431,715 $82,110 23,000 $38,065
2023-12 5,000 $7,050 0 $0 0 $0
2023-09 3,467,778 $0 0 $0 0 $0
2023-08 0 $0 0 $0 22,436 $0
2023-06 7,000 $11,830 0 $0 0 $0
2023-05 14,000 $20,160 0 $0 0 $0
2022-09 1,040,000 $1,300,000 0 $0 0 $0
2022-06 60,037 $99,901 0 $0 0 $0
2022-03 25,000 $54,000 0 $0 0 $0
2021-05 10,000 $66,500 0 $0 0 $0
2021-03 0 $0 52,500 $625,775 52,500 $114,500
2020-12 0 $0 37,829 $196,332 41,667 $192,501
2020-11 5,000 $22,150 0 $0 0 $0
2020-05 1,000 $4,690 0 $0 0 $0
2019-11 10,000 $30,900 0 $0 0 $0
2019-08 2,500 $10,075 0 $0 0 $0
2019-05 2,253 $9,980 0 $0 0 $0
2019-03 31,625 $118,716 24,390 $85,565 43,334 $65,001
2018-09 5,000 $17,500 0 $0 0 $0

Table 3. Detailed insider trading at Niagen Bioscience, Inc. (NAGE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-11-14 Pamir Ozan (Chief Financial Officer) Buy 6,685 6.83 45,658
2025-04-09 Fried Robert N (Chief Executive Officer) Option Ex 66,667 3.30 220,001
2025-03-07 Lopez Carlos Luis (SVP, General Counsel) Buy 273 7.86 2,145
2024-12-13 Jaksch Frank L Jr (Director) Sale 37,161 6.19 229,952
2024-12-13 Jaksch Frank L Jr (Director) Option Ex 50,001 3.66 183,003
2024-11-22 Pamir Ozan (Chief Financial Officer) Buy 2,907 7.36 21,395
2024-08-23 Patrick Kristin (Director) Sale 23,000 3.57 82,110
2024-08-23 Patrick Kristin (Director) Option Ex 23,000 1.66 38,065
2024-08-20 Radiant Treasure Ltd Buy 11,408,715 .00 0
2024-08-20 Mayspin Management Ltd Sale 11,408,715 .00 0
2023-12-01 Gerber Brianna (Chief Financial Officer) Buy 5,000 1.41 7,050
2023-09-06 Shing Li Ka (Director) Buy 3,467,778 .00 0
2023-08-12 Gerber Brianna (Chief Financial Officer) Option Ex 22,436 .00 0
2023-06-12 Jaksch Frank L Jr (Director) Buy 7,000 1.69 11,830
2023-05-31 Fried Robert N (Chief Executive Officer) Buy 7,000 1.42 9,940
2023-05-25 Rubin Steven D Buy 7,000 1.46 10,220
2022-09-30 Dvorak International Ltd (10% Owner) Buy 960,000 1.25 1,200,000
2022-09-30 Fried Robert N (Cheif Executive Officer) Buy 80,000 1.25 100,000
2022-06-16 Dvorak International Ltd (10% Owner) Buy 60,037 1.66 99,901
2022-03-16 Fried Robert N (CEO) Buy 25,000 2.16 54,000
2021-05-13 Fried Robert N (CEO) Buy 10,000 6.65 66,500
2021-03-16 Block Stephen A Sale 20,000 13.17 263,400
2021-03-16 Block Stephen A Option Ex 20,000 2.60 52,100
2021-03-15 Block Stephen A Sale 32,500 11.15 362,375
2021-03-15 Block Stephen A Option Ex 32,500 1.92 62,400
2020-12-10 Jaksch Frank L Jr (EXECUTIVE CHAIRMAN OF BOARD) Sale 37,829 5.19 196,332
2020-12-10 Jaksch Frank L Jr (EXECUTIVE CHAIRMAN OF BOARD) Option Ex 41,667 4.62 192,501
2020-11-06 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 5,000 4.43 22,150
2020-05-19 Fried Robert N (CEO) Buy 1,000 4.69 4,690
2019-11-14 Fried Robert N (CEO) Buy 10,000 3.09 30,900
2019-08-23 Fried Robert N (CEO) Buy 2,500 4.03 10,075
2019-05-21 Fried Robert N (CEO) Buy 2,253 4.43 9,980
2019-03-15 Fried Robert N (CEO) Buy 5,000 3.80 19,000
2019-03-15 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 6,900 3.85 26,565
2019-03-14 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 6,725 3.99 26,832
2019-03-12 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 7,300 3.62 26,426
2019-03-11 Jaksch Frank L Jr (EXECUTIVE CHAIRMAN OF BOARD) Sale 14,390 3.50 50,365
2019-03-11 Jaksch Frank L Jr (EXECUTIVE CHAIRMAN OF BOARD) Option Ex 33,334 1.50 50,001
2019-03-11 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 5,700 3.49 19,893
2019-03-11 Block Stephen A Sale 10,000 3.52 35,200
2019-03-11 Block Stephen A Option Ex 10,000 1.50 15,000
2018-09-11 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 5,000 3.50 17,500
2018-05-18 Farr Kevin M (CHIEF FINANCIAL OFFICER) Buy 5,000 3.83 19,150
2018-05-17 Friedman Mark J (GENERAL COUNSEL) Buy 3,000 3.60 10,800
2018-05-16 Jaksch Frank L Jr (CEO) Buy 4,300 3.56 15,308
2018-05-15 Jaksch Frank L Jr (CEO) Buy 5,500 3.61 19,855
2018-03-29 Jaksch Frank L Jr (CEO) Sale 474 4.60 2,180
2018-03-29 Jaksch Frank L Jr (CEO) Option Ex 474 4.50 2,133
2018-03-27 Jaksch Frank L Jr (CEO) Sale 24,578 4.60 113,058
2018-03-27 Jaksch Frank L Jr (CEO) Option Ex 24,578 4.50 110,601
2018-01-11 Jaksch Frank L Jr (CEO) Sale 6,249 6.50 40,618
2018-01-11 Jaksch Frank L Jr (CEO) Option Ex 6,249 4.50 28,120
2018-01-10 Jaksch Frank L Jr (CEO) Sale 22,130 6.52 144,287
2018-01-10 Jaksch Frank L Jr (CEO) Option Ex 22,130 4.50 99,585
2017-12-21 Jaksch Frank L Jr (CEO) Sale 58,400 6.19 361,496
2017-12-21 Jaksch Frank L Jr (CEO) Option Ex 58,400 4.50 262,800
2017-11-17 Li Ka Shing (10% Owner) Buy 731,707 4.10 2,999,998
2017-08-25 Allen Stephen R. Buy 2,000 3.31 6,620
2017-08-18 Chau Hoi Shuen Solina Holly (10% Owner) Buy 786,167 2.60 2,044,034
2017-08-18 Li Ka Shing (10% Owner) Buy 1,179,250 2.60 3,066,050
2017-08-15 Fried Robert N (PRESIDENT, CHIEF STRATEGY OFF.) Buy 10,000 3.15 31,500
2017-05-24 Chau Hoi Shuen Solina Holly (10% Owner) Buy 2,521,526 2.60 6,555,967
2017-05-24 Li Ka Shing (10% Owner) Buy 3,782,288 2.60 9,833,948
2017-05-19 Allen Stephen R. Buy 3,000 3.20 9,600
2017-03-20 Allen Stephen R. Buy 2,000 2.81 5,620
2016-12-12 Jaksch Frank L Jr (CEO, PRESIDENT) Buy 2,000 2.42 4,840
2016-09-01 Jaksch Frank L Jr (CEO, PRESIDENT) Buy 1,500 3.32 4,980
2016-09-01 Fried Robert N Buy 15,000 3.39 50,850
2016-06-20 Rhonemus Troy Allen (CHIEF OPERATING OFFICER) Buy 7,800 3.34 26,075
2016-01-29 Fried Robert N Sale 5,063 1.26 6,379

Insider trading activities including stock purchases, stock sales, and option exercises of NAGE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Niagen Bioscience, Inc. (symbol NAGE, CIK number 1386570) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.